BMS-986465
- Generic Name
- BMS-986465
A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants
Phase 1
Terminated
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 267
- Registration Number
- NCT06144697
- Locations
- 🇺🇸
Local Institution - 0003, Austin, Texas, United States
🇺🇸Local Institution - 0001, Anaheim, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath